121 related articles for article (PubMed ID: 3910730)
41. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Granowetter L; Wells H; Lange BJ
Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
[TBL] [Abstract][Full Text] [Related]
42. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
[TBL] [Abstract][Full Text] [Related]
43. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
[TBL] [Abstract][Full Text] [Related]
44. Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
Yataganas X; Rombos Y; Vayopoulos G; Meletis J; Avlami A
Chemotherapy; 1991; 37(5):376-81. PubMed ID: 1804599
[TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
[TBL] [Abstract][Full Text] [Related]
46. Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia.
Daenen S; Erjavec Z; Uges DR; De Vries-Hospers HG; De Jonge P; Halie MR
Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):188-92. PubMed ID: 7614958
[TBL] [Abstract][Full Text] [Related]
47. [Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].
Marie JP; Vekhoff A; Cony-Makhoul P; Fière D; Guy H; Herbrecht R; Milpied N; Pico JL; Plantier I
Presse Med; 1995 Feb; 24(8):397-401. PubMed ID: 7899419
[TBL] [Abstract][Full Text] [Related]
48. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
[TBL] [Abstract][Full Text] [Related]
49. Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Marie JP; Vekhoff A; Pico JL; Guy H; Andremont A; Richet H
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():57-64. PubMed ID: 9688452
[TBL] [Abstract][Full Text] [Related]
50. A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients.
Wang FD; Liu CY; Hsu HC; Gau JP; Chau WK; Haung ML; Ho CH
Chemotherapy; 1999; 45(5):370-9. PubMed ID: 10473925
[TBL] [Abstract][Full Text] [Related]
51. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
[TBL] [Abstract][Full Text] [Related]
52. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
[TBL] [Abstract][Full Text] [Related]
53. Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children.
Jacobs RF; Vats TS; Pappa KA; Chaudhary S; Kletzel M; Becton DL
Infection; 1993; 21(4):223-8. PubMed ID: 8225625
[TBL] [Abstract][Full Text] [Related]
54. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Young M; Plosker GL
Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
[TBL] [Abstract][Full Text] [Related]
55. Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
Scaglione C; López H; Fernández A; Marcenac F; Garay G; Dupont J; Pavlovsky S
Medicina (B Aires); 1981; 41 Suppl():29-34. PubMed ID: 6954341
[No Abstract] [Full Text] [Related]
56. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
Sato T; Kobayashi R; Yasuda K; Kaneda M; Iguchi A; Kobayashi K
Pediatr Blood Cancer; 2008 Dec; 51(6):774-7. PubMed ID: 18661495
[TBL] [Abstract][Full Text] [Related]
57. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
[TBL] [Abstract][Full Text] [Related]
58. Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors.
Gasparini G; Benedetti M; Fassio T; Canobbio L; Figoli F; Galligioni E; Talamini R; Toffoli G; Tumolo S
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):113-20. PubMed ID: 3549581
[TBL] [Abstract][Full Text] [Related]
59. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
Mackie MJ; Reilly JT; Purohit S; Bartzokas CA
J Antimicrob Chemother; 1986 May; 17 Suppl C():219-24. PubMed ID: 3522529
[TBL] [Abstract][Full Text] [Related]
60. Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.
Nováková I; Donnelly P; De Pauw B
Scand J Infect Dis; 1990; 22(6):705-11. PubMed ID: 2284577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
